JPS5512411B2 - - Google Patents

Info

Publication number
JPS5512411B2
JPS5512411B2 JP2767374A JP2767374A JPS5512411B2 JP S5512411 B2 JPS5512411 B2 JP S5512411B2 JP 2767374 A JP2767374 A JP 2767374A JP 2767374 A JP2767374 A JP 2767374A JP S5512411 B2 JPS5512411 B2 JP S5512411B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2767374A
Other languages
Japanese (ja)
Other versions
JPS50121418A (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP2767374A priority Critical patent/JPS5512411B2/ja
Priority to BE154189A priority patent/BE826498A/xx
Priority to FR7507336A priority patent/FR2263744B1/fr
Priority to US05/557,408 priority patent/US3976764A/en
Priority to DK97875AA priority patent/DK142802B/da
Priority to SE7502725A priority patent/SE409286B/xx
Priority to ES435500A priority patent/ES435500A1/es
Priority to DE2510620A priority patent/DE2510620C2/de
Priority to CA221,903A priority patent/CA1054056A/en
Priority to NL7502952A priority patent/NL7502952A/xx
Priority to GB10214/75A priority patent/GB1507521A/en
Priority to CH315475A priority patent/CH604719A5/xx
Publication of JPS50121418A publication Critical patent/JPS50121418A/ja
Publication of JPS5512411B2 publication Critical patent/JPS5512411B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
JP2767374A 1974-03-12 1974-03-12 Expired JPS5512411B2 (en:Method)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (en:Method) 1974-03-12 1974-03-12
BE154189A BE826498A (fr) 1974-03-12 1975-03-10 Composition therapeutique solide a usage interne
FR7507336A FR2263744B1 (en:Method) 1974-03-12 1975-03-10
US05/557,408 US3976764A (en) 1974-03-12 1975-03-11 Solid therapeutic preparation remaining in stomach
DK97875AA DK142802B (da) 1974-03-12 1975-03-11 Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken.
SE7502725A SE409286B (sv) 1974-03-12 1975-03-11 Sett att framstella en fast, terapeutisk beredning for oralt bruk
ES435500A ES435500A1 (es) 1974-03-12 1975-03-11 Un procedimiento para la obtencion de un preparado terapeu- tico solido.
DE2510620A DE2510620C2 (de) 1974-03-12 1975-03-11 Festes, zum Einnehmen bestimmtes, im Magensaft schwimmfähiges Arzneimittel
CA221,903A CA1054056A (en) 1974-03-12 1975-03-12 Solid therapeutic preparation remaining in stomach
NL7502952A NL7502952A (nl) 1974-03-12 1975-03-12 Vast therapeutisch preparaat voor inwendig gebruik.
GB10214/75A GB1507521A (en) 1974-03-12 1975-03-12 Dosage unit
CH315475A CH604719A5 (en:Method) 1974-03-12 1975-03-12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (en:Method) 1974-03-12 1974-03-12

Publications (2)

Publication Number Publication Date
JPS50121418A JPS50121418A (en:Method) 1975-09-23
JPS5512411B2 true JPS5512411B2 (en:Method) 1980-04-02

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2767374A Expired JPS5512411B2 (en:Method) 1974-03-12 1974-03-12

Country Status (12)

Country Link
US (1) US3976764A (en:Method)
JP (1) JPS5512411B2 (en:Method)
BE (1) BE826498A (en:Method)
CA (1) CA1054056A (en:Method)
CH (1) CH604719A5 (en:Method)
DE (1) DE2510620C2 (en:Method)
DK (1) DK142802B (en:Method)
ES (1) ES435500A1 (en:Method)
FR (1) FR2263744B1 (en:Method)
GB (1) GB1507521A (en:Method)
NL (1) NL7502952A (en:Method)
SE (1) SE409286B (en:Method)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61107782U (en:Method) * 1984-12-19 1986-07-08
JP2013530200A (ja) * 2010-07-05 2013-07-25 ヤゴテック アーゲー 投与形態

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
DE3278491D1 (en) * 1981-07-15 1988-06-23 Key Pharma Sustained release theophyline
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
JPH05507717A (ja) * 1990-06-25 1993-11-04 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー 軟ゼラチンカプセル剤中で使用するための高められた溶解特性を有するアマンタジン塩酸塩懸濁液
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (en:Method) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
BR9908911A (pt) 1998-03-19 2001-10-02 Bristol Myers Squibb Co Sistema bifásico e processo de distribuição por liberação controlada de substâncias farmacêuticas de alta solubilidade
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
EP1596841B1 (en) * 2003-02-21 2008-10-08 LEK Pharmaceuticals D.D. Therapeutic system comprising amoxicillin and clavulanic acid
EP1680098A4 (en) * 2003-11-04 2012-06-13 Supernus Pharmaceuticals Inc DELAYED RELEASE OF POSITIVELY-LOADED PHARMACOLOGICALLY EFFECTIVE MOLECULES FROM A POLYMER-CONTAINING MATRIX WITH POLARIZED OXYGENATOMES
WO2008062440A2 (en) * 2006-09-04 2008-05-29 Panacea Biotec Limited Programmable buoyant delivery technology
WO2010020098A1 (zh) * 2008-08-18 2010-02-25 北京天衡药物研究院 胃滞留药物释出系统及其制备方法和用途
WO2009087665A2 (en) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Novel gastroretentive drug delivery system
GB2462022B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
JP5594484B2 (ja) * 2009-07-06 2014-09-24 杏林製薬株式会社 中空構造を有する錠剤
EP2731609A1 (en) * 2011-07-14 2014-05-21 APeT Holding B.V. Nicotinamide compositions and the therapeutic use thereof
AU2012322323B2 (en) 2011-10-11 2016-04-21 Sun Pharmaceutical Industries Limited A gastroretentive dosage system and process of preparation thereof
EP2872140A1 (en) * 2012-07-16 2015-05-20 APeT Holding B.V. Gastro-retentive drug delivery system
PT2719376E (pt) 2012-10-12 2015-07-06 Omya Int Ag Sistemas de formulação e ministração de medicamentos gastrorretentivos e o seu método de preparação usando carbonato de cálcio funcionalizado
JP6681390B2 (ja) 2014-06-11 2020-04-15 マサチューセッツ インスティテュート オブ テクノロジー 腸溶性エラストマー
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
AU2016257711A1 (en) 2015-05-01 2017-10-26 Massachusetts Institute Of Technology Triggerable shape memory induction devices
US11576859B2 (en) 2015-10-23 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
US11992552B2 (en) 2015-12-08 2024-05-28 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
CA3018011A1 (en) * 2016-03-18 2017-09-21 Grunenthal Gmbh Floating pharmaceutical dosage form
JP7189772B2 (ja) 2016-05-27 2022-12-14 リンドラ セラピューティクス， インコーポレイティド 胃内滞留システムのための材料構造物
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
US11576866B2 (en) 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
JP7274428B2 (ja) 2017-06-09 2023-05-16 リンドラ セラピューティクス， インコーポレイティド 放出速度調節フィルムを有する胃内滞留システム
JP7624750B2 (ja) * 2020-03-02 2025-01-31 クラフト ヘルス プライベート リミテッド 持続的薬物放出のための経口剤形
ES2955784T3 (es) * 2020-10-14 2023-12-07 Hannes Bichsel Granos biogranulados espumados
WO2023166225A1 (en) * 2022-03-04 2023-09-07 APET Holding B.V. Digestive enzyme formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61107782U (en:Method) * 1984-12-19 1986-07-08
JP2013530200A (ja) * 2010-07-05 2013-07-25 ヤゴテック アーゲー 投与形態
US9314430B2 (en) 2010-07-05 2016-04-19 Jagotec Ag Floating gastric retentive dosage form
JP2017014257A (ja) * 2010-07-05 2017-01-19 ヤゴテック アーゲー 剤形
US10076500B2 (en) 2010-07-05 2018-09-18 Jagotec Ag Floating gastric retentive dosage form

Also Published As

Publication number Publication date
GB1507521A (en) 1978-04-19
SE409286B (sv) 1979-08-13
CH604719A5 (en:Method) 1978-09-15
DK142802B (da) 1981-02-02
DE2510620A1 (de) 1975-09-18
SE7502725L (en:Method) 1975-09-15
ES435500A1 (es) 1977-02-01
US3976764A (en) 1976-08-24
DK142802C (en:Method) 1981-09-21
JPS50121418A (en:Method) 1975-09-23
FR2263744B1 (en:Method) 1978-11-24
BE826498A (fr) 1975-06-30
DE2510620C2 (de) 1984-01-05
DK97875A (en:Method) 1975-09-13
CA1054056A (en) 1979-05-08
FR2263744A1 (en:Method) 1975-10-10
NL7502952A (nl) 1975-09-16

Similar Documents

Publication Publication Date Title
JPS5512411B2 (en:Method)
AU495883B2 (en:Method)
AU7459074A (en:Method)
AU486824B2 (en:Method)
AU495870B2 (en:Method)
AR198841Q (en:Method)
AU8476175A (en:Method)
AU7474774A (en:Method)
AU7465874A (en:Method)
BG19670A1 (en:Method)
BG19893A1 (en:Method)
AU482115A (en:Method)
AU482149A (en:Method)
AU482294A (en:Method)
AU481765A (en:Method)
AU481479A (en:Method)
BG20448A1 (en:Method)
AU7253373A (en:Method)
AU481082A (en:Method)
AU480925A (en:Method)
AU480470A (en:Method)
AU480209A (en:Method)
BE836321A (en:Method)
BG20474A1 (en:Method)
AU479870A (en:Method)